Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,508 | 52 | 98.6% |
| Education | $21.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $486.88 | 17 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $230.20 | 12 | $0 (2024) |
| PFIZER INC. | $155.01 | 4 | $0 (2021) |
| Foundation Medicine, Inc. | $119.23 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $118.93 | 1 | $0 (2018) |
| Amgen Inc. | $71.86 | 1 | $0 (2018) |
| EMD Serono, Inc. | $46.91 | 2 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $43.11 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $37.79 | 2 | $0 (2019) |
| Tactile Systems Technology Inc | $26.62 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.27 | 6 | Novartis Pharmaceuticals Corporation ($98.41) |
| 2023 | $177.85 | 9 | EMD Serono, Inc. ($46.91) |
| 2022 | $168.44 | 9 | E.R. Squibb & Sons, L.L.C. ($120.78) |
| 2021 | $73.95 | 4 | PFIZER INC. ($21.00) |
| 2020 | $36.67 | 2 | E.R. Squibb & Sons, L.L.C. ($18.82) |
| 2019 | $218.25 | 13 | E.R. Squibb & Sons, L.L.C. ($53.65) |
| 2018 | $687.90 | 9 | E.R. Squibb & Sons, L.L.C. ($259.27) |
| 2017 | $20.00 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($20.00) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Recon-Skin and Wound | ||||||
| 05/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Oncology | ||||||
| 04/17/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: DESMOID TUMORS | ||||||
| 03/20/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Oncology | ||||||
| 01/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: HORMONE THERAPY | ||||||
| 07/18/2023 | EMD Serono, Inc. | TEPMETKO (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: Oncology | ||||||
| 07/14/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: Oncology | ||||||
| 04/12/2023 | EMD Serono, Inc. | TEPMETKO (Drug) | Food and Beverage | Cash or cash equivalent | $27.41 | General |
| Category: Oncology | ||||||
| 03/24/2023 | Hologic Sales and Service, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Surgical | ||||||
| 03/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| 03/13/2023 | PolyNovo North America LLC | — | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| 01/19/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Oncology | ||||||
| 01/13/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/16/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $23.19 | General |
| 10/28/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $33.60 | General |
| Category: Oncology | ||||||
| 08/05/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| 05/27/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.43 | General |
| Category: Oncology | ||||||
| 05/27/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $1.37 | General |
| Category: Oncology | ||||||
| 05/20/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| Category: Oncology | ||||||
| 05/20/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $1.63 | General |
| Category: Oncology | ||||||
| 05/03/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Oncology | ||||||
| 04/26/2022 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2021 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 831 | 1,556 | $317,835 | $92,011 |
| 2022 | 12 | 897 | 11,124 | $442,470 | $132,174 |
| 2021 | 14 | 987 | 7,353 | $441,540 | $133,683 |
| 2020 | 12 | 830 | 1,353 | $221,940 | $70,272 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 341 | $119,350 | $33,911 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 118 | $50,150 | $16,567 | 33.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $26,400 | $8,535 | 32.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 104 | $28,600 | $7,612 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 101 | $25,250 | $7,224 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $16,650 | $4,750 | 28.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 36 | $18,000 | $4,106 | 22.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $15,225 | $3,401 | 22.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 169 | 356 | $8,900 | $2,592 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 163 | 316 | $6,320 | $2,546 | 40.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 52 | $2,600 | $657.50 | 25.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 26 | $390.00 | $109.20 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 379 | $132,650 | $38,712 | 29.2% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2022 | 15 | 9,220 | $73,760 | $23,518 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 95 | 155 | $65,875 | $23,018 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 72 | 72 | $39,600 | $12,761 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 139 | $34,750 | $10,119 | 29.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 118 | $32,450 | $7,878 | 24.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $18,000 | $4,531 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $12,150 | $3,717 | 30.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 182 | 452 | $11,300 | $3,424 | 30.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $9,425 | $2,192 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 177 | 438 | $8,760 | $1,280 | 14.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 75 | $3,750 | $1,026 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 124 | 344 | $120,400 | $37,953 | 31.5% |
About Dr. Kenneth Angelino, M.D
Dr. Kenneth Angelino, M.D is a Hematology & Oncology healthcare provider based in Rockville Centre, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1376802405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Angelino, M.D has received a total of $1,529 in payments from pharmaceutical and medical device companies, with $146.27 received in 2024. These payments were reported across 53 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,508).
As a Medicare-enrolled provider, Angelino has provided services to 3,545 Medicare beneficiaries, totaling 21,386 services with total Medicare billing of $428,141. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Rockville Centre, NY
- Active Since 05/09/2012
- Last Updated 08/21/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1376802405
Products in Payments
- OPDIVO (Biological) $189.13
- KISQALI (Drug) $136.83
- FOUNDATIONONE (Device) $119.23
- IMFINZI (Drug) $118.93
- SUTENT (Drug) $105.93
- Neulasta (Biological) $71.86
- TEPMETKO (Drug) $46.91
- Imbruvica (Drug) $43.11
- ORGOVYX (Drug) $40.95
- PIQRAY (Drug) $40.01
- KEYTRUDA (Biological) $37.79
- Flexitouch Plus (Device) $26.62
- OGSIVEO (Drug) $24.66
- IMBRUVICA (Drug) $24.22
- Integra (Device) $23.20
- PROMACTA (Drug) $23.06
- CoolSeal Generator (Device) $20.32
- XARELTO (Drug) $20.17
- Xofigo (Drug) $20.00
- OPDUALAG (Drug) $19.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Rockville Centre
Dr. Abdul Mundia, Md, MD
Hematology & Oncology — Payments: $18,207
Richard Lee, Md, MD
Hematology & Oncology — Payments: $9,697
Doron Weiner, Md, MD
Hematology & Oncology — Payments: $7,051
Valerie Kremer, M.d, M.D
Hematology & Oncology — Payments: $3,229
Dr. Magdy Shaaban, M.d, M.D
Hematology & Oncology — Payments: $3,091
Leonard Kessler, Md, MD
Hematology & Oncology — Payments: $73.56